Medical Oddities: A Cancer Clue Some Patients Can’t See
Conexiant
January 21, 2026
Color vision deficiency (CVD) may negatively impact survival rates in bladder cancer patients compared to those without CVD.
Bladder cancer patients with CVD showed a 52% higher 20-year mortality rate than matched controls without CVD.
Colorectal cancer outcomes were similar for patients with and without CVD, indicating different clinical implications.
The study suggests that inability to see red should not lower suspicion for bladder cancer, especially with visible blood.
This research highlights the unexpected connections between sensory perception and cancer outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Author
Affiliations:
Specialties:
Areas of Expertise: